Home › Trial NCT01197885
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
- Trial IDNCT01197885
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorGanymed Pharmaceuticals GmbH
- Enrollment54
- Start date2010-09-03
- ConditionsSolid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.